Related Experiment Videos
New atypical antipsychotics. Experience and utility in the elderly
1Department of Psychiatry, University of Pittsburg, School of Medicine, Pennyslvania, USA.
Drugs & Aging
|March 24, 1998
Summary
Atypical antipsychotics offer promise for elderly patients due to fewer side effects. However, age-related factors and limited studies necessitate further research for safe and effective use in late-life psychoses.
Area of Science:
- Geriatric Psychiatry
- Pharmacology
- Clinical Therapeutics
Background:
- Atypical antipsychotics present a promising therapeutic option for elderly individuals.
- These agents exhibit a lower risk of acute extrapyramidal adverse effects compared to traditional antipsychotics.
- However, treatment in older adults requires careful consideration of pharmacokinetic changes and drug-drug interactions.
Purpose of the Study:
- To review the current evidence and considerations for using atypical antipsychotics in elderly patients with late-life psychoses.
- To highlight the need for further controlled clinical studies in this specific population.
Main Methods:
- Review of existing literature on atypical antipsychotics in geriatric populations.
- Analysis of pharmacokinetic and pharmacodynamic considerations in the elderly.
- Evaluation of current evidence regarding efficacy and safety in late-life psychoses.
Main Results:
- Atypical antipsychotics show potential benefits for elderly patients, particularly regarding extrapyramidal side effects.
- Age-related pharmacokinetic alterations and potential drug-drug interactions are critical factors in treatment.
- Current evidence for efficacy in late-life psychoses is largely based on case series and extrapolation from younger populations.
Conclusions:
- Atypical antipsychotics may be beneficial for elderly patients, but require cautious management.
- Further rigorous, controlled clinical trials are essential to establish definitive efficacy and safety profiles in elderly patients with late-life psychoses.